These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer]. Ouyang T, Li JF, Wang TF, Lin BY. Zhonghua Wai Ke Za Zhi; 2005 Mar 01; 43(5):298-300. PubMed ID: 15842936 [Abstract] [Full Text] [Related]
10. Ultrasonographic detection of interpectoral (Rotter's) node involvement in breast cancer. Oran I, Memiş A, Ustün EE. J Clin Ultrasound; 1996 Mar 01; 24(9):519-22. PubMed ID: 8906484 [Abstract] [Full Text] [Related]
11. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI. J Am Coll Surg; 1996 Dec 01; 183(6):575-82. PubMed ID: 8957459 [Abstract] [Full Text] [Related]
17. Treatment of carcinoma of the breast by modified radical mastectomy. Papatestas AE, Lesnick GJ. Surg Gynecol Obstet; 1975 Jan 01; 140(1):22-6. PubMed ID: 1209469 [Abstract] [Full Text] [Related]
18. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S. J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [Abstract] [Full Text] [Related]